Miller Matthew P
SEC CIK 1915822 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STLN | Starling Oncology, Inc. | COO | 243.0K | $70.0K | $1,171 | 6 | 2022-03-21 | 2023-03-17 |
Most active insiders at STLN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chernett Jorey | 10% | $2.69M | — |
| 2 | Hively Brad | Dir | — | $2.00M |
| 3 | Kaushal Mohit | Dir | — | $335.1K |
| 4 | Podnos Yale | Chief Medical Off | — | $276.4K |
| 5 | Pacala Mark L | Dir | — | $200.0K |
| 6 | Carter Robert Ross | CFO | — | $879.32 |
| 7 | England Kristin | Chief Administrative Off | — | — |
| 8 | Langsam Jeffrey | Chief Clinical Off | — | — |
| 9 | Ling Gabriel | Dir | — | — |
| 10 | TOI M, LLC | Dir | — | — |
Miller Matthew P made no open-market trades at STLN in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-21 | 2023-03-17 | STLN | Starling Oncology, Inc. | Miller Matthew P | COO | A - Grant | $0.00 | +67.7K | 243.0K | +39% | $0 |
| 2022-12-20 | 2022-12-16 | STLN | Starling Oncology, Inc. | Miller Matthew P | COO | P - Purchase | $0.95 | +73.7K | 175.3K | +72% | +$70.0K | |
| A | 2022-11-22 | 2022-11-15 | STLN | Starling Oncology, Inc. | Miller Matthew P | COO | S - Sale | $2.03 | -577 | 78.0K | -0.7% | -$1,171 |
| D | 2022-11-21 | 2022-11-17 | STLN | Starling Oncology, Inc. | Miller Matthew P | COO | A - Grant | $0.00 | +23.6K | 101.6K | +30% | $0 |
| 2022-11-17 | 2022-11-15 | STLN | Starling Oncology, Inc. | Miller Matthew P | COO | D - Sale to Iss | $2.03 | -577 | 78.0K | -0.7% | -$1,171 | |
| DM | 2022-03-23 | 2022-03-21 | STLN | Starling Oncology, Inc. | Miller Matthew P | COO | A - Grant | $0.00 | +28.0K | 78.6K | +55% | $0 |
Purchase Sale Sale after option exercise All abbreviations